Last week saw legal professionals from across the life sciences community meet in Amsterdam for the Kisaco Pharma & Biotech Patent Litigation Europe Summit. As one of the key annual industry … [Read More...] about Reflections from the Pharma & Biotech Patent Litigation Europe Summit
In the summer, the Government consulted on various measures to ease the Biodiversity Net Gain (BNG) 'obligations' (cost) on small and medium sized developers. A range of proposals were put forward for … [Read More...] about Biodiversity Net Gain – difficult decisions kicked into the long grass
Nature-based risks and opportunities are starting to find their way onto more pension scheme trustee meeting agendas and into scheme investment strategies. To explore what this means in practice, … [Read More...] about Nature-based investment risks and opportunities for pension schemes
The Regional Court of Munich I recently issued a landmark decision in the GEMA vs. OpenAI case on the use of copyright-protected content in AI training. This article takes a closer look at the case … [Read More...] about Copyright ends the data rush: No mining for AI chatbots